About Vital Laboratories
Vital Laboratories is a Healthcare company based in Valsad (India) founded in 1998. Vital Laboratories is engaged in manufacturing active pharmaceutical ingredients. It operates on a B2B2C model. The company has 630 employees. Its Indian entity Vital Laboratories Private Limited reported revenue of ₹357 Cr. Vital Laboratories offers products and services including Quinine Derivatives, Hyoscine Derivatives, and Artemisinin Derivatives. Its focus areas include Pharmaceuticals and Active Pharmaceutical Ingredients. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Vital Laboratories is involved in the production of active pharmaceutical ingredients (APIs) with a focus on anti-malarial, anti-spasmodic, anti-viral, and anti-bacterial segments. The company, established in 1998, is recognized as one of the largest manufacturers of Quinine Derivatives globally. Operations are supported by backward integration, including cultivation in farms in Australia for Hyoscine derivatives. A diverse portfolio of over 45 APIs is maintained, covering various therapeutic areas. Strategic partnerships are established with major pharmaceutical companies in India and worldwide, ensuring a global reach. Growth is driven by a philosophy of manufacturing APIs from scratch, securing reliability as a trusted partner in the pharmaceutical sector.
- Headquarters Valsad, India
- Employees 630
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vitallab.com
- Legal Name Vital Laboratories Private Limited
- Date of Incorporation 19 Jan, 1998
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹357 Cr
FY 2025 · +7% YoY
- Net Loss-₹1.00 Cr
FY 2025 · 0% margin
- EBITDA₹46.53 Cr
FY 2025 · 13% margin
- Employee Count630
Associated legal entities of Vital Laboratories
Vital Laboratories operates through Vital Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vital Laboratories Private Limited CIN U24100MH1998PTC113058 | Active | 19 Jan 1998 | Mumbai, Maharashtra | ₹357 Cr | 630 | 3 | View details |
Products & Services of Vital Laboratories
Vital Laboratories offers a comprehensive portfolio of products and services, including Quinine Derivatives, Hyoscine Derivatives, and Artemisinin Derivatives.
Quinine derivatives are manufactured for anti-malarial therapeutic use.
Hyoscine derivatives are produced for anti-spasmodic medical applications.
Artemisinin derivatives are developed for anti-malarial treatment purposes.
Board of directors of Vital Laboratories Private Limited (Vital Laboratories)
Vital Laboratories Private Limited is the primary company behind Vital Laboratories. The board of Vital Laboratories Private Limited currently have 3 directors; the longest-serving is Rajiv Shrigopal Bajaj, appointed in 2001. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajiv Shrigopal Bajaj DIN 01659971 | Director | 31 Mar 2001 | 25 yrs 7 mo | Vital Laboratories Private Limited |
| Shrigopal Rangnath Bajaj DIN 00983198 | Director | 31 Mar 2001 | 25 yrs 7 mo | Vital Laboratories Private Limited |
| Kintubhai Madhabhai Bhutaka DIN 10861068 | Director | 04 Dec 2024 | 1 yr 11 mo | Vital Laboratories Private Limited |
People of Vital Laboratories
5 people are tracked at Vital Laboratories (1 in leadership, 4 in team); the tracked headcount is 630.
| Name | Role | Group |
|---|---|---|
| Director | Leadership | |
Avnish Rajput | Quality Control Manager | Team |
Nandagopal Chakraborthy | Project And Purchase | Team |
Niteesh Mishra | IT Manager | Team |
Ajaz Ahmad | Senior Executive - IT | Team |
Complete people profiles for Vital Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vital Laboratories
Figures of Vital Laboratories Private Limited, the primary company behind Vital Laboratories, for FY 2025. Revenue was ₹357 Cr (+7% year on year). Net loss was -₹1.00 Cr (0% margin). EBITDA was ₹46.53 Cr (13% margin). Revenue has grown at a compounded annual rate of 0% over three years and -2% over five years.
- ₹357 CrRevenue · FY 2025 · +7% YoY
- -₹1.00 CrNet loss · 0% margin
- ₹46.53 CrEBITDA · 13% margin
- ₹9.11 CrPaid-up capital
- 630Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vital Laboratories Private Limited are on its company page.
Detailed financial statements for Vital Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Vital Laboratories
Vital Laboratories has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Vital Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vital Laboratories
The website of Vital Laboratories (vitallab.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 31.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vital Laboratories
Complete news archive for Vital Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vital Laboratories
Vital Laboratories was founded in 1998.
Vital Laboratories is headquartered in Valsad, India. It is registered at Valsad, Gujarat, India.
Vital Laboratories has 630 employees.
The primary company behind Vital Laboratories, Vital Laboratories Private Limited, reported revenue of ₹357 Cr for FY 2025, up 7% year on year.
Vital Laboratories is involved in the production of active pharmaceutical ingredients (APIs) with a focus on anti-malarial, anti-spasmodic, anti-viral, and anti-bacterial segments. The company, established in 1998, is recognized as one of the largest manufacturers of Quinine Derivatives globally. Operations are supported by backward integration, including cultivation in farms in Australia for Hyoscine derivatives. A diverse portfolio of over 45 APIs is maintained, covering various therapeutic areas. Strategic partnerships are established with major pharmaceutical companies in India and worldwide, ensuring a global reach. Growth is driven by a philosophy of manufacturing APIs from scratch, securing reliability as a trusted partner in the pharmaceutical sector.
Vital Laboratories's top competitors include Laurus Labs, Symbiotec and SeQuent.
Vital Laboratories offers Quinine Derivatives, Hyoscine Derivatives, and Artemisinin Derivatives.
Vital Laboratories operates through Vital Laboratories Private Limited.
The legal entities of Vital Laboratories currently have 3 directors, including Rajiv Shrigopal Bajaj, Shrigopal Rangnath Bajaj, Kintubhai Madhabhai Bhutaka.